Evidence map›Paper›PMID 31396758›Full record

ArticlePflugers Archiv : European journal of physiology2019

AT

Willian Costa-Ferreira, Lucas Gomes-de-Souza, Carlos C Crestani

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Willian Costa-FerreiraLaboratory of Pharmacology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rodovia Araraquara-Jaú Km 01 (Campus Universitário), Campus Ville, Araraquara, SP, 14800-903, Brazil.
Lucas Gomes-de-SouzaLaboratory of Pharmacology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rodovia Araraquara-Jaú Km 01 (Campus Universitário), Campus Ville, Araraquara, SP, 14800-903, Brazil.
Carlos C CrestaniLaboratory of Pharmacology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rodovia Araraquara-Jaú Km 01 (Campus Universitário), Campus Ville, Araraquara, SP, 14800-903, Brazil. carlos.crestani@unesp.br.ORCID 0000-0002-1942-858X
Universidade Federal de São Carlos · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The medial amygdaloid nucleus (MeA) is a limbic structure that has been demonstrated to be part of the central circuitry regulating baroreflex function. However, the local neurochemical mechanisms involved in baroreflex control by this forebrain structure is poorly understood. Thus, in the present study, we investigated the specific role of AT

Indexed as

Angiotensin II Type 1 Receptor BlockersAngiotensin II Type 2 Receptor BlockersAnimalsBaroreflexBlood PressureCorticomedial Nuclear ComplexHeartHeart RateImidazolesLosartanMaleProto-Oncogene MasProto-Oncogene ProteinsPyridinesRatsRats, WistarAngiotensin II Type 1 Receptor BlockersAngiotensin II Type 2 Receptor BlockersImidazolesLosartanPD 123319Proto-Oncogene MasProto-Oncogene ProteinsPyridinesReceptor, Angiotensin, Type 1Receptor, Angiotensin, Type 2Receptors, G-Protein-CoupledA-779AmygdalaAT2 receptorBlood pressureHeart rateLosartanMAS receptorPD123319

Identifiers

PMID31396758
OpenAlexW2967896709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.